Pure-play medical device maker Medtronic (NYSE:MDT) invested further into its emerging market strategy, promising an additional $6 million for cardiovascular disease and diabetes research in India.
Medical device giant Medtronic (NYSE:MDT) is making new moves in Asia, launching commercial sales of its Resolute Integrity stent on the Japanese market and announcing the 1st research & development facility in China.